|
US7014998B2
(en)
|
2000-09-30 |
2006-03-21 |
Yale University |
Screening immunomodulatory agents by CTLA-4 upregulation
|
|
US20050069538A1
(en)
|
2003-09-18 |
2005-03-31 |
Gregorio Aversa |
Therapeutic binding molecules
|
|
GB0103389D0
(en)
*
|
2001-02-12 |
2001-03-28 |
Novartis Ag |
Organic compounds
|
|
AU2002351204B2
(en)
*
|
2001-12-03 |
2008-07-10 |
Abgenix, Inc. |
Anti-CD45RB antibodies for use in treating autoimmune disease and transplant rejection
|
|
EP2075256A2
(en)
|
2002-01-14 |
2009-07-01 |
William Herman |
Multispecific binding molecules
|
|
US20030175270A1
(en)
*
|
2002-01-17 |
2003-09-18 |
Josef Penninger |
Methods of regulating cytokine receptor signaling
|
|
EP1551452A4
(en)
*
|
2002-07-01 |
2006-08-30 |
Savient Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR THERAPEUTIC TREATMENT
|
|
WO2004019891A2
(en)
*
|
2002-08-28 |
2004-03-11 |
Sangstat Medical Corporation |
Methods and compostions for immune tolerance
|
|
US20040047858A1
(en)
*
|
2002-09-11 |
2004-03-11 |
Blumberg Richard S. |
Therapeutic anti-BGP(C-CAM1) antibodies and uses thereof
|
|
CA2535583A1
(en)
*
|
2003-08-25 |
2005-03-03 |
Pangenetics B.V. |
Method of inducing immune tolerance
|
|
ES2341341T3
(es)
*
|
2003-09-18 |
2010-06-18 |
Novartis Ag |
Anticuerpos terapeuticos humanizados contra las isoformas cd45.
|
|
WO2007087453A2
(en)
*
|
2006-01-27 |
2007-08-02 |
Cellerant Therapeutics, Inc. |
Compositions and methods for treating haematological proliferative disorders
|
|
US20100034782A1
(en)
*
|
2006-05-31 |
2010-02-11 |
Nader Najafian |
Methods of Using Anti-Thymocyte Globulin and Related Agents
|
|
JP5570808B2
(ja)
|
2006-08-18 |
2014-08-13 |
アルゴス・セラピューティクス・インコーポレーテッド |
併用療法におけるｃｄ８３の使用
|
|
EP2063905B1
(en)
|
2006-09-18 |
2014-07-30 |
Raptor Pharmaceutical Inc |
Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
|
|
CN101646455A
(zh)
|
2007-02-07 |
2010-02-10 |
财团法人阪大微生物病研究会 |
用于癌症的治疗剂
|
|
WO2012117855A1
(ja)
|
2011-02-28 |
2012-09-07 |
ナパジェン ファーマ，インコーポレテッド |
核酸多糖複合体
|
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
|
EP2742944B1
(en)
*
|
2011-08-10 |
2018-06-27 |
Napajen Pharma, Inc. |
Immune tolerance inducer
|
|
GB201409558D0
(en)
|
2014-05-29 |
2014-07-16 |
Ucb Biopharma Sprl |
Method
|
|
GB201412658D0
(en)
|
2014-07-16 |
2014-08-27 |
Ucb Biopharma Sprl |
Molecules
|
|
GB201412659D0
(en)
|
2014-07-16 |
2014-08-27 |
Ucb Biopharma Sprl |
Molecules
|
|
ES2726645T3
(es)
*
|
2014-08-01 |
2019-10-08 |
Inst Nat Sante Rech Med |
Un anticuerpo anti-CD45RC para usar como medicamento
|
|
GB201601075D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibodies molecules
|
|
GB201601077D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibody molecule
|
|
GB201601073D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibodies
|
|
EP3858388B1
(en)
|
2015-09-28 |
2024-07-03 |
Regents of the University of Minnesota |
Chimeric antigen receptor (car) t cells as therapeutic interventions for gvhd
|
|
GB201521391D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
GB201521389D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Method
|
|
GB201521393D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
GB201521383D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl And Ucb Celltech |
Method
|
|
GB201521382D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
CN109641051A
(zh)
|
2016-06-17 |
2019-04-16 |
美真达治疗公司 |
用于耗尽细胞的组合物和方法
|
|
WO2017219029A2
(en)
|
2016-06-17 |
2017-12-21 |
Magenta Therapeutics, Inc. |
Compositions and methods for the depletion of cd117+cells
|
|
CA3042683A1
(en)
|
2016-11-07 |
2018-05-11 |
Coimmune, Inc. |
Bispecific antibodies that modulate tlr-4 signaling and uses thereof
|
|
KR102725761B1
(ko)
|
2017-01-20 |
2024-11-04 |
하이델베르크 파마 리서치 게엠베하 |
Cd137+ 세포의 고갈을 위한 조성물 및 방법
|
|
EP3514541A1
(de)
|
2018-01-17 |
2019-07-24 |
Siemens Healthcare Diagnostics Products GmbH |
Verfahren zur quantitativen bestimmung eines therapeutischen tnf-alpha inhibitors
|
|
EP3917313A4
(en)
*
|
2019-02-01 |
2023-02-08 |
Actinium Pharmaceuticals, Inc. |
ANTI-CD45 MOLECULES AND DERIVATIVES THEREOF
|
|
CN111707833A
(zh)
*
|
2020-06-19 |
2020-09-25 |
徐州医科大学 |
小鼠血管内外淋巴细胞识别的方法及其应用
|
|
MX2023007384A
(es)
|
2020-12-21 |
2023-07-05 |
Allogene Therapeutics Inc |
Car con puerta cd45 activado por proteasa.
|
|
WO2022169825A1
(en)
|
2021-02-03 |
2022-08-11 |
Mozart Therapeutics, Inc. |
Binding agents and methods of using the same
|
|
JPWO2022196719A1
(cg-RX-API-DMAC10.html)
|
2021-03-17 |
2022-09-22 |
|
|
|
WO2023076876A1
(en)
|
2021-10-26 |
2023-05-04 |
Mozart Therapeutics, Inc. |
Modulation of immune responses to viral vectors
|
|
US20230399375A1
(en)
|
2022-04-15 |
2023-12-14 |
Kyverna Therapeutics, Inc. |
Methods and compositions for treating autoimmune disease
|
|
WO2023240064A1
(en)
|
2022-06-08 |
2023-12-14 |
Kyverna Therapeutics, Inc. |
Methods and compositions for treating autoimmune disease
|
|
CN120554513B
(zh)
*
|
2025-07-28 |
2025-11-21 |
杭州华大生命科学研究院 |
一种抗cd45抗体及其应用
|